Nanobiotix S.A.

NASDAQ: NBTX
Share price (3/28/25): $3.61
Market cap (3/28/25): $170 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020 – amended

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement for primary offering

Free writing prospectus

Free writing prospectus

Prospectus supplement for primary offering

Ownership Filter

Baillie Gifford & Co

Artal International S.C.A.

Qatar Investment Authority

Johnson & Johnson

Baillie Gifford & Co

News Filter

Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC

Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference

Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

SEC STAFF LETTER